Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Sep 4;6(10):2011-2014.
doi: 10.1002/ccr3.1790. eCollection 2018 Oct.

Bleomycin-induced pulmonary toxicity and treatment with infliximab: A case report

Victor Ge  1 , Iouri Banakh  2 , Ravindranath Tiruvoipati  1   3 , Kavi Haji  1   3
Affiliations
Case Reports

Bleomycin-induced pulmonary toxicity and treatment with infliximab: A case report

Victor Ge et al. Clin Case Rep. .

Abstract

Given the current understanding of bleomycin-induced pneumonitis (BIP), the use of tumor necrosis factor alpha (TNF-α) inhibitors such as infliximab for late-stage disease appears to be of limited benefit. Further research regarding prevention and management of advanced BIP is required.

Keywords: bleomycin; infliximab; intensive care; pulmonary toxicity; respiratory failure; treatment outcome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CT chest demonstrating extensive consolidation and ground glass opacification
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sleijfer S. Bleomycin‐induced pneumonitis. Chest. 2001;120(2):617‐624. - PubMed
    1. Bleomycin product information document submitted to Therapeutic Goods of Australia, Aspen Pharma Pty Ltd, Published on June 26, 2006. https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&i.... Accessed June 24, 2018.
    1. Reinert T, Serodio da Rocha Baldotto C, Pereira Nunes F, Alves de Souza Scheliga A. Bleomycin‐induced lung injury. J Cancer Res. 2013;480608:9.
    1. Banakh I, Lam A, Tiruvoipati R, Carney I, Botha J. imatinib for bleomycin induced pulmonary toxicity: a case report and evidence‐base review. Clin Case Rep. 2016;4(5):486‐490. - PMC - PubMed
    1. Brugge SS, Claasen HR, Dawson L. Drug induced lung injury‐a case of fatal Bleomycin interstitial pneumonitis. Netherlands J Critical Care. 2013;17:25‐29.

Publication types

LinkOut - more resources